A citation-based method for searching scientific literature

Sara Badodi, Nicola Pomella, Xinyu Zhang, Gabriel Rosser, John Whittingham, Maria Victoria Niklison-Chirou, Yau Mun Lim, Sebastian Brandner, Gillian Morrison, Steven M Pollard, Christopher D Bennett, Steven C Clifford, Andrew Peet, M Albert Basson, Silvia Marino. Nat Commun 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Histological subtype of medulloblastoma frequently changes upon recurrence.
Julia Pöschl, Arend Koch, Ulrich Schüller. Acta Neuropathol 2015
9
50

Spatial heterogeneity in medulloblastoma.
A Sorana Morrissy, Florence M G Cavalli, Marc Remke, Vijay Ramaswamy, David J H Shih, Borja L Holgado, Hamza Farooq, Laura K Donovan, Livia Garzia, Sameer Agnihotri,[...]. Nat Genet 2017
75
50

Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas.
Annette Künkele, Katleen De Preter, Lukas Heukamp, Theresa Thor, Kristian W Pajtler, Wolfgang Hartmann, Michel Mittelbronn, Michael A Grotzer, Hedwig E Deubzer, Frank Speleman,[...]. Neuro Oncol 2012
44
50

The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways.
Zhaohui Feng, Wenwei Hu, Elisa de Stanchina, Angelika K Teresky, Shengkan Jin, Scott Lowe, Arnold J Levine. Cancer Res 2007
434
50

Actionable molecular biomarkers in primary brain tumors.
Verena Staedtke, Omar Dildar a Dzaye, Matthias Holdhoff. Trends Cancer 2016
20
50

Intertumoral Heterogeneity within Medulloblastoma Subgroups.
Florence M G Cavalli, Marc Remke, Ladislav Rampasek, John Peacock, David J H Shih, Betty Luu, Livia Garzia, Jonathon Torchia, Carolina Nor, A Sorana Morrissy,[...]. Cancer Cell 2017
447
50

Humanized Stem Cell Models of Pediatric Medulloblastoma Reveal an Oct4/mTOR Axis that Promotes Malignancy.
Matko Čančer, Sonja Hutter, Karl O Holmberg, Gabriela Rosén, Anders Sundström, Jignesh Tailor, Tobias Bergström, Alexandra Garancher, Magnus Essand, Robert J Wechsler-Reya,[...]. Cell Stem Cell 2019
14
50

Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas.
R Sutter, O Shakhova, H Bhagat, H Behesti, C Sutter, S Penkar, A Santuccione, R Bernays, F L Heppner, U Schüller,[...]. Oncogene 2010
64
50

Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions.
Laura Magri, Marco Cambiaghi, Manuela Cominelli, Clara Alfaro-Cervello, Marco Cursi, Mauro Pala, Alessandro Bulfone, Jose Manuel Garcìa-Verdugo, Letizia Leocani, Fabio Minicucci,[...]. Cell Stem Cell 2011
161
50

Medulloblastoma-translating discoveries from the bench to the bedside.
Amar J Gajjar, Giles W Robinson. Nat Rev Clin Oncol 2014
106
50

Deconstructing Sonic Hedgehog Medulloblastoma: Molecular Subtypes, Drivers, and Beyond.
Jesus Garcia-Lopez, Rahul Kumar, Kyle S Smith, Paul A Northcott. Trends Genet 2021
8
50

Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.
David W Ellison, James Dalton, Mehmet Kocak, Sarah Leigh Nicholson, Charles Fraga, Geoff Neale, Anna M Kenney, Dan J Brat, Arie Perry, William H Yong,[...]. Acta Neuropathol 2011
325
50

Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.
Marcel Kool, David T W Jones, Natalie Jäger, Paul A Northcott, Trevor J Pugh, Volker Hovestadt, Rosario M Piro, L Adriana Esparza, Shirley L Markant, Marc Remke,[...]. Cancer Cell 2014
432
50

Author Correction: mTOR at the nexus of nutrition, growth, ageing and disease.
Grace Y Liu, David M Sabatini. Nat Rev Mol Cell Biol 2020
9
50

A mouse model of the most aggressive subgroup of human medulloblastoma.
Daisuke Kawauchi, Giles Robinson, Tamar Uziel, Paul Gibson, Jerold Rehg, Cuilan Gao, David Finkelstein, Chunxu Qu, Stanley Pounds, David W Ellison,[...]. Cancer Cell 2012
189
50

Gene signatures associated with mouse postnatal hindbrain neural stem cells and medulloblastoma cancer stem cells identify novel molecular mediators and predict human medulloblastoma molecular classification.
Daniela Corno, Mauro Pala, Manuela Cominelli, Barbara Cipelletti, Ketty Leto, Laura Croci, Valeria Barili, Federico Brandalise, Raffaella Melzi, Alessandra Di Gregorio,[...]. Cancer Discov 2012
16
50

Linking the p53 tumour suppressor pathway to somatic cell reprogramming.
Teruhisa Kawamura, Jotaro Suzuki, Yunyuan V Wang, Sergio Menendez, Laura Batlle Morera, Angel Raya, Geoffrey M Wahl, Juan Carlos Izpisúa Belmonte. Nature 2009
819
50

Medulloblastoma.
Paul A Northcott, Giles W Robinson, Christian P Kratz, Donald J Mabbott, Scott L Pomeroy, Steven C Clifford, Stefan Rutkowski, David W Ellison, David Malkin, Michael D Taylor,[...]. Nat Rev Dis Primers 2019
164
50

Molecular subgroups of medulloblastoma: the current consensus.
Michael D Taylor, Paul A Northcott, Andrey Korshunov, Marc Remke, Yoon-Jae Cho, Steven C Clifford, Charles G Eberhart, D Williams Parsons, Stefan Rutkowski, Amar Gajjar,[...]. Acta Neuropathol 2012
50

mTORC1-Mediated Inhibition of 4EBP1 Is Essential for Hedgehog Signaling-Driven Translation and Medulloblastoma.
Chang-Chih Wu, Shirui Hou, Brent A Orr, Bryan R Kuo, Yong Ha Youn, Taren Ong, Fanny Roth, Charles G Eberhart, Giles W Robinson, David J Solecki,[...]. Dev Cell 2017
26
50

Medulloblastoma: experimental models and reality.
Julia E Neumann, Fredrik J Swartling, Ulrich Schüller. Acta Neuropathol 2017
15
50

An animal model of MYC-driven medulloblastoma.
Yanxin Pei, Colin E Moore, Jun Wang, Alok K Tewari, Alexey Eroshkin, Yoon-Jae Cho, Hendrik Witt, Andrey Korshunov, Tracy-Ann Read, Julia L Sun,[...]. Cancer Cell 2012
193
50

p53 Deletion or Hotspot Mutations Enhance mTORC1 Activity by Altering Lysosomal Dynamics of TSC2 and Rheb.
Stuti Agarwal, Catherine M Bell, Shirley M Taylor, Richard G Moran. Mol Cancer Res 2016
20
50

Tuberous sclerosis complex suppression in cerebellar development and medulloblastoma: separate regulation of mammalian target of rapamycin activity and p27 Kip1 localization.
Bobby Bhatia, Paul A Northcott, Dolores Hambardzumyan, Baskaran Govindarajan, Daniel J Brat, Jack L Arbiser, Eric C Holland, Michael D Taylor, Anna Marie Kenney. Cancer Res 2009
33
50

Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma.
Rahul Kumar, Kyle S Smith, Maximilian Deng, Colt Terhune, Giles W Robinson, Brent A Orr, Anthony P Y Liu, Tong Lin, Catherine A Billups, Murali Chintagumpala,[...]. J Clin Oncol 2021
6
50

Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449.
Charles M Rudin, Christine L Hann, John Laterra, Robert L Yauch, Christopher A Callahan, Ling Fu, Thomas Holcomb, Jeremy Stinson, Stephen E Gould, Barbara Coleman,[...]. N Engl J Med 2009
747
50

The transcriptional landscape of Shh medulloblastoma.
Patryk Skowron, Hamza Farooq, Florence M G Cavalli, A Sorana Morrissy, Michelle Ly, Liam D Hendrikse, Evan Y Wang, Haig Djambazian, Helen Zhu, Karen L Mungall,[...]. Nat Commun 2021
5
50

miR-135a Inhibits Cancer Stem Cell-Driven Medulloblastoma Development by Directly Repressing Arhgef6 Expression.
Katayoun Hemmesi, Mario Leonardo Squadrito, Pieter Mestdagh, Valentina Conti, Manuela Cominelli, Ignazio S Piras, Lucia Sergi Sergi, Sara Piccinin, Roberta Maestro, Pietro L Poliani,[...]. Stem Cells 2015
29
50

Establishment of a human medulloblastoma cell line and its heterotransplantation into nude mice.
P F Jacobsen, D J Jenkyn, J M Papadimitriou. J Neuropathol Exp Neurol 1985
199
50

The Master Observational Trial: A New Class of Master Protocol to Advance Precision Medicine.
Dane Dickson, Jennifer Johnson, Raymond Bergan, Rebecca Owens, Vivek Subbiah, Razelle Kurzrock. Cell 2020
14
50

Current medulloblastoma subgroup specific clinical trials.
Eric M Thompson, David Ashley, Daniel Landi. Transl Pediatr 2020
9
50

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas.
Marcel Kool, Andrey Korshunov, Marc Remke, David T W Jones, Maria Schlanstein, Paul A Northcott, Yoon-Jae Cho, Jan Koster, Antoinette Schouten-van Meeteren, Dannis van Vuurden,[...]. Acta Neuropathol 2012
585
50


Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma.
Silvia Buonamici, Juliet Williams, Michael Morrissey, Anlai Wang, Ribo Guo, Anthony Vattay, Kathy Hsiao, Jing Yuan, John Green, Beatriz Ospina,[...]. Sci Transl Med 2010
350
50


Medulloblastomics revisited: biological and clinical insights from thousands of patients.
Volker Hovestadt, Olivier Ayrault, Fredrik J Swartling, Giles W Robinson, Stefan M Pfister, Paul A Northcott. Nat Rev Cancer 2020
48
50


4E-BP1, a multifactor regulated multifunctional protein.
Xiaoyu Qin, Bin Jiang, Yanjie Zhang. Cell Cycle 2016
108
50

Pharmacological mTOR targeting enhances the antineoplastic effects of selective PI3Kα inhibition in medulloblastoma.
Frank Eckerdt, Jessica Clymer, Jonathan B Bell, Elspeth M Beauchamp, Gavin T Blyth, Stewart Goldman, Leonidas C Platanias. Sci Rep 2019
9
50

Evasion of Cell Senescence Leads to Medulloblastoma Progression.
Lukas Tamayo-Orrego, Chia-Lun Wu, Nicolas Bouchard, Ahmed Khedher, Shannon M Swikert, Marc Remke, Patryk Skowron, Michael D Taylor, Frédéric Charron. Cell Rep 2016
26
50

Targeting mTOR as a Therapeutic Approach in Medulloblastoma.
Juncal Aldaregia, Ainitze Odriozola, Ander Matheu, Idoia Garcia. Int J Mol Sci 2018
8
50

Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease.
Rebecca M Hill, Sanne Kuijper, Janet C Lindsey, Kevin Petrie, Ed C Schwalbe, Karen Barker, Jessica K R Boult, Daniel Williamson, Zai Ahmad, Albert Hallsworth,[...]. Cancer Cell 2015
116
50

Multipotent CD15+ cancer stem cells in patched-1-deficient mouse medulloblastoma.
Ryan J Ward, Lilian Lee, Kevin Graham, Thevagi Satkunendran, Koichi Yoshikawa, Erick Ling, Lauren Harper, Ryan Austin, Erica Nieuwenhuis, Ian D Clarke,[...]. Cancer Res 2009
126
50

IRF8 is a critical transcription factor for transforming microglia into a reactive phenotype.
Takahiro Masuda, Makoto Tsuda, Ryohei Yoshinaga, Hidetoshi Tozaki-Saitoh, Keiko Ozato, Tomohiko Tamura, Kazuhide Inoue. Cell Rep 2012
168
50

Childhood cerebellar tumours mirror conserved fetal transcriptional programs.
Maria C Vladoiu, Ibrahim El-Hamamy, Laura K Donovan, Hamza Farooq, Borja L Holgado, Yogi Sundaravadanam, Vijay Ramaswamy, Liam D Hendrikse, Sachin Kumar, Stephen C Mack,[...]. Nature 2019
132
50

Clonal selection drives genetic divergence of metastatic medulloblastoma.
Xiaochong Wu, Paul A Northcott, Adrian Dubuc, Adam J Dupuy, David J H Shih, Hendrik Witt, Sidney Croul, Eric Bouffet, Daniel W Fults, Charles G Eberhart,[...]. Nature 2012
297
50

Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
Edward C Schwalbe, Janet C Lindsey, Sirintra Nakjang, Stephen Crosier, Amanda J Smith, Debbie Hicks, Gholamreza Rafiee, Rebecca M Hill, Alice Iliasova, Thomas Stone,[...]. Lancet Oncol 2017
221
50

Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma.
Nataliya Zhukova, Vijay Ramaswamy, Marc Remke, Elke Pfaff, David J H Shih, Dianna C Martin, Pedro Castelo-Branco, Berivan Baskin, Peter N Ray, Eric Bouffet,[...]. J Clin Oncol 2013
251
50

Subtypes of medulloblastoma have distinct developmental origins.
Paul Gibson, Yiai Tong, Giles Robinson, Margaret C Thompson, D Spencer Currle, Christopher Eden, Tanya A Kranenburg, Twala Hogg, Helen Poppleton, Julie Martin,[...]. Nature 2010
512
50

SATB1 targets chromatin remodelling to regulate genes over long distances.
Dag Yasui, Masaru Miyano, Shutao Cai, Patrick Varga-Weisz, Terumi Kohwi-Shigematsu. Nature 2002
371
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.